Skip to main content
Article
Prevalence and predictors of osteoporosis treatment in nursing home residents with known osteoporosis or recent fracture
Quantitative Health Sciences Publications and Presentations
  • Cathleen S. Colon-Emeric, Duke University
  • Kenneth W. Lyles, Duke University
  • Deborah Levine, University of Alabama
  • Paul House, Carolinas Center for Medical Excellence
  • Anna P. Schenck, Carolinas Center for Medical Excellence
  • Joel Gorospe, Carolinas Center for Medical Excellence
  • Mary Fermazin, Health Services Advisory Group
  • Kristi Oliver, University of Alabama
  • Jeroan J. Allison, University of Massachusetts Medical School
  • N. Weisman, University of Alabama
  • A. Xie, University of Alabama
  • Jeffrey R. Curtis, University of Alabama
  • Kenneth G. Saag, University of Alabama
UMMS Affiliation
Department of Quantitative Health Sciences
Date
11-23-2006
Document Type
Article
Medical Subject Headings
Aged; Aged, 80 and over; Arizona; Bone Density Conservation Agents; Calcitonin; Calcium, Dietary; California; Diphosphonates; Female; Fractures, Bone; Hip; Humans; Male; Middle Aged; *Nursing Homes; Osteoporosis; Osteoporosis, Postmenopausal; Prevalence; Protective Devices; Quality of Health Care; Treatment Outcome; Vitamin D
Abstract
Summary: We studied nursing home residents with osteoporosis or recent fracture to determine the frequency and predictors of osteoporosis treatment. There was wide variation in performance, and both clinical and systems variables predicted use. This study shows that improvement in osteoporosis care is possible and important for many nursing homes. INTRODUCTION: We determined the prevalence and predictors of osteoporosis evaluation and treatment in high-risk nursing home residents. METHODS: We identified 67 nursing facilities in North Carolina and Arizona with > 10 residents with osteoporosis or recent hip fracture. Medical records (n=895) were abstracted for osteoporosis evaluation [dual-energy X-ray absorptiometry (DXA), vitamin D level, serum calcium), treatment (calcium, vitamin D, osteoporosis medication, hip protectors), clinical, and systems covariates. Data were analyzed at the facility level using mixed models to account for the complex nesting of residents within providers and nursing facilities. RESULTS: Calcium and vitamin D was prescribed for 69% of residents, bisphosphonates for 19%, calcitonin for 14%, other pharmacologic therapies for 6%, and hip protectors for 2%. Overall, 36% received any bone protection (medication or hip protectors), with wide variation among facilities (0-85%). Factors significantly associated with any bone protection included female gender [odds ratio (OR) 2.4, (1.5-3.7)] and nonurban/suburban location [1.5, (1.1-2.2)]. Residents with esophagitis, peptic ulcer disease (PUD), or dysphagia [0.6, (0.4-0.9)] and alcohol abuse [0.2, (0.0-0.9)] were less likely to receive treatment. CONCLUSIONS: There is substantial variation in the quality of osteoporosis treatment across nursing homes. Interventions that improve osteoporosis quality of care are needed.
Rights and Permissions
Citation: Osteoporos Int. 2007 Apr;18(4):553-9. Epub 2006 Nov 21. Link to article on publisher's site
Related Resources
Link to Article in PubMed
Citation Information
Cathleen S. Colon-Emeric, Kenneth W. Lyles, Deborah Levine, Paul House, et al.. "Prevalence and predictors of osteoporosis treatment in nursing home residents with known osteoporosis or recent fracture" Vol. 18 Iss. 4 (2006) ISSN: 0937-941X (Linking)
Available at: http://works.bepress.com/jeroan_allison/53/